GoodRx (GDRX) Offers Foundayo GLP-1 Medication for $149 Monthly
Published on 4/9/2026

AI Summary
Summarized by AI from the source belowGoodRx (GDRX) has announced that it will offer the Foundayo GLP-1 medication starting at a price of $149 per month. This move provides a lower-cost option for patients seeking weight management treatments. The availability of this medication may impact the market for weight-loss pharmaceuticals by introducing competition. As healthcare costs continue to be a focus for consumers and providers, this pricing could influence purchasing decisions in the sector.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News

Economy
Retiring at 64: $51K Healthcare Gap Before Medicare Starts
Jul 6

Earnings
CVS (CVS) Reports 3% Net Income Margin, $100.4 Billion Revenue
Jul 5

Earnings
UHS Stock Price Target Revised to $197, 24% Upside Anticipated
Jul 4

Earnings
UPS (NYSE: UPS) Invests $48 Million for Temperature-Controlled Facilities
Jul 4